Flinton Capital Management’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Flinton Capital Management’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-8,148	Closed	-$101K	–	882
2018 Q1	$101K	Sell	8,148 -24,500	-75%	-$298K	﹤0.01%	749
2017 Q4	$456K	Sell	32,648 -16,352	-33%	-$240K	0.02%	457
2017 Q3	$823K	Sell	49,000 -6,104	-11%	-$99.3K	0.03%	306
2017 Q2	$927K	Sell	55,104 -18,396	-25%	-$275K	0.03%	277
2017 Q1	$1.14M	Hold	73,500	–	–	0.04%	250
2016 Q4	$1.1M	Buy	+73,500	New	+$1.03M	0.05%	229

Other funds holding OXFD

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Flinton Capital Management's OXFD Position: Q2 2018 in Review

Flinton Capital Management sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q2 2018, closing a stake of 8,148 shares — an estimated $101K sold.

Flinton Capital Management first reported a position in OXFD in Q4 2016 and held it in 6 quarters. The position peaked at $1.14M in Q1 2017. 77 funds tracked by Wall St. Rank hold OXFD as of Q2 2018.

Flinton Capital Management reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q2 2018 after selling out during the quarter.
Flinton Capital Management sold 8,148 Oxford Immunotec Global PLC Ordinary Shares shares in Q2 2018, an estimated $101K.
Flinton Capital Management first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2016 and held it in 6 quarters.
Flinton Capital Management's Oxford Immunotec Global PLC Ordinary Shares position peaked at $1.14M in Q1 2017.
77 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q2 2018.

Based on Flinton Capital Management's 13F filing for Q2 2018, filed 13 Aug 2018.